Board

Board Changes

As of 1st April and following an internal restructure as the business continues to grow, Tissuemed is pleased to announce two new additions to its Board of Directors. Peter Maver (Head of Sales for over two years) becomes Managing Director and …

Read more >

Posted in:

Tissuemed Profitable

Developer and manufacturer of surgical sealants, Tissuemed has been cash generative for the first time in its history. The accounts for year ended March 31st 2017 show the Leeds-based company profiting from early success in China, together with growth in other …

Read more >

Posted in:

Gordon Sutherland joins Tissuemed

Gordon Sutherland has been appointed as a non-executive Director to the Board. Gordon has worked in the healthcare industry for over 30 years and has held senior positions with Johnson & Johnson, ConvaTec-Bristol Myers Squibb and Baxter Biosurgery Europe and …

Read more >

Posted in: ,

Tissuemed – New CEO announced

Tissuemed are pleased to announce that Dr. David Mandley has been appointed as the company’s new CEO.  David has worked for over 10 years at Tissuemed and he has been a Director of the Company for four years. Prior to …

Read more >

Posted in: ,